A couple of weeks ago, NICE announced the approval of the artificial pancreas on the NHS. A hybrid, closed-loop system, it will help Type 1 Diabetes (T1D) patients manage their blood glucose levels without the need to constantly monitor themselves with a continuous glucose monitor or a manual finger prick test.
A watershed moment in diabetes technology, the artificial pancreas could be prescribed to more than 105,000 patients in England. Diagnosed with type 1 diabetes in 2015, I could form part of that statistic.
